KRRO 8-K 2026-11-05

Korro Bio, Inc. (KRRO) 8-K dated 2026-11-05 — accession 0001193125-26-448532.

Korro Bio, Inc. (KRRO) is a biotechnology company listed on US.

Korro Bio, Inc. filed a 8-K on 2026-11-05. Accession 0001193125-26-448532.

This 8-K covers: Agreement ended (Item 1.02), Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported KRRO revenue for 2025-12-31 was $6.4M. Net income was -$117.3M. Revenue was up 181.5% from 2024-12-31 to 2025-12-31. KRRO currently screens at market cap $159.8M.

Not investment advice. The KRRO SEC hub lists recent forms. The stock page is the research view.